Karyn Ho, B.A.Sc.
karyn.ho@utoronto.ca
Project Bio
Our goal is to use Herceptin, a monoclonal antibody that recognizes and binds to the HER2 surface antigen, to actively target polymeric nanoparticles to breast cancer cells. These nanoparticles will be loaded with an anticancer drug for localized release both at established tumour sites and at the locations of metastasized cancer cells. In this way, we will reduce the harmful impact that systemic drug administration can have on healthy tissues while increasing drug efficacy against diseased tissues.
Employment and Education
Ph.D.
University of Toronto
Sept. 2005 - present
Research Assistant
Michael Smith Laboratories
May - Aug. 2005
Process Engineer (Co-op)
Canfor Northwood Pulp Mill
Jan. - Aug. 2004
Research Assistant (Hydrometallurgy)
Placer Dome Research Centre
May - Aug. 2003
Biochemical Engineer (Co-op)
UBC Biotechnology Laboratory
May - Dec. 2002
B.A.Sc.
University of British Columbia
Sept. 2000 - Apr. 2005
Awards
NSERC CGSM Scholarship
